Tokyo Tape
Sign in
5% STAKE4883.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Modalis Therapeutics to 5.42%

Stake history

0%5%10%15%20%15.95%PriorPrior: 15.95% · prior ratio stated in S100U2AC11.95%Jul 19Jul 19: 11.95% · S100U2AC10.84%Jul 31Jul 31: 10.84% · S100U4O97.74%Aug 16Aug 16: 7.74% · S100U8RP6.26%Aug 19Aug 19: 6.26% · S100U8X26.54%Aug 20Aug 20: 6.54% · S100U93J5.42%Aug 28Aug 28: 5.42% · S100UABN
0%5%10%15%20%15.95%PriorPrior: 15.95% · prior ratio stated in S100U2AC11.95%Jul 19Jul 19: 11.95% · S100U2AC10.84%Jul 31Jul 31: 10.84% · S100U4O97.74%Aug 16Aug 16: 7.74% · S100U8RP6.26%Aug 19Aug 19: 6.26% · S100U8X26.54%Aug 20Aug 20: 6.54% · S100U93J5.42%Aug 28Aug 28: 5.42% · S100UABN

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-28 11:23 JST concerning Modalis Therapeutics Corporation. Reported holding ratio: 5.42%, previous report: 6.54%.

Stock price4883 · View chart ↗

Open the price chart on TradingView.

Source: EDINET S100UABN ↗ · PDL1.0 · Not investment advice